Combination Therapy of Rosiglitazone, a Peroxisome Proliferator-Activated Receptor-? Ligand, and NMDA Receptor Antagonist (MK-801) on Experimental Embolic Stroke in Rats
Author:
Publisher
Wiley
Subject
Pharmacology,Toxicology,General Medicine
Reference34 articles.
1. Rodent models of focal stroke: Size, mechanism, and purpose
2. Rosiglitazone and 15-deoxy-Δ12,14-prostaglandin J2 Cause Potent Neuroprotection after Experimental Stroke through Noncompletely Overlapping Mechanisms
3. An improved version of embolic model of brain ischemic injury in the rat
4. Failures and successes of NMDA receptor antagonists: Molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults
5. Neuroprotective Effects of MK-801 in Different Rat Stroke Models for Permanent Middle Cerebral Artery Occlusion
Cited by 34 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Targeting NMDA receptors with an antagonist is a promising therapeutic strategy for treating neurological disorders;Behavioural Brain Research;2024-08
2. Neuroprotective effect of ischemic postconditioning against hyperperfusion and its mechanisms of neuroprotection;Journal of Research in Medical Sciences;2024-05
3. Integrative Pharmacology in the Treatment of Substance Use Disorders;Journal of Dual Diagnosis;2023-12-20
4. Research progress and perspectives of N-methyl-D-aspartate receptor in myocardial and cerebral ischemia-reperfusion injury: A review;Medicine;2023-10-20
5. The role of Nrf2 in neural stem/progenitors cells: From maintaining stemness and self-renewal to promoting differentiation capability and facilitating therapeutic application in neurodegenerative disease;Ageing Research Reviews;2021-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3